MB "Biotechnologiniai projektai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
97,602 |
- |
4,475 |
4,475 |
- |
0.56 |
0.01 |
40.43 |
4.58 |
69,440 |
488 |
15,175 |
54,753 |
2022 |
---|
129,665 |
- |
-35,661 |
-35,661 |
- |
0.16 |
0.03 |
11.63 |
-27.50 |
33,779 |
956 |
12,901 |
21,834 |
2023 |
---|
101,015 |
- |
-39,486 |
-39,486 |
- |
-0.15 |
-3.30 |
11.48 |
-39.09 |
-5,707 |
18,805 |
9,801 |
3,297 |
Register and
explore Okredo data2023 |
---|
101,015 |
- |
-39,486 |
-39,486 |
- |
-0.15 |
-3.30 |
11.48 |
-39.09 |
-5,707 |
18,805 |
9,801 |
3,297 |
Register and
explore Okredo data2023
Turnover (€)
101,015 €-22 % *
Sales per employee (€)
-Profit before tax (€)
-39,486 €-11 % *
Net Profit (€)
-39,486 €-11 % *
Profit per employee (€)
-Working capital requirement
-0.15 -193.75 % *
Debt-to-equity ratio
-3.30 -11,100.00 % *
Total profitability (%)
11.48 %-1.29 % *
Net profitability (%)
-39.09 %-42.15 % *
Equity (€)
-5,707 €-117 % *
Amounts Payable And Liabilities (€)
18,805 €1,867 % *
Non-current Assets (€)
9,801 €-24 % *
CurrentAssets (€)
3,297 €-85 % *